The passage of azidodeoxythymidine into and within the central nervous system: Does it follow the parent compound, thymidine?

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1211-1218

  Thomas, Sarah A ^a   Segal, Malcolm B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MANNITOL; NITROBENZYLTHIOINOSINE; THYMIDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN PERFUSION; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CISTERNA MAGNA; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DIFFUSION; DRUG TRANSPORT; DRUG UPTAKE; FEMALE; GUINEA PIG; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CENTRAL NERVOUS SYSTEM; GUINEA PIGS; THYMIDINE; ZIDOVUDINE;

EID: 0030972182     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. 14C]thymidine in mice. J. Pharmacol. Exp. Ther. 257: 479-486, 1991.
2. AYRE, S. G., SKALETSKI, B. AND MOSNAIM, A. D.: Blood-brain barrier passage of azidodeoxythymidine in rats: Effect of insulin. Res. Commun. Chem. Pathol. Pharmacol. 63: 45-52, 1989.
3. BALIS, F. M., PIZZO, P. A., MURPHY, R. F., EDDY, J., JAROSINSKI, P. F., FALLOON J., BRODER, S. AND POPLACK, D. G.: The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann. Intern. Med. 110: 279-285, 1989.
4. BLASBERG, R., PATLAK, C. S. AND FENSTERMACHER, J. D.: Intrathecal chemotherapy: Brain tissue profiles after ventriculo-cisternal perfusion. J. Pharmacol. Exp. Ther. 195: 78-83, 1975.
5. BRADBURY, M. W. AND DAVSON, H.: The transport of urea, creatinine and certain monosaccharides between blood and fluid perfusing the cerebral ventricular system in rabbits. J. Physiol. (Lond.) 170: 195-211, 1964.
6. BRAUN, L. D., MILLER, L. P., PARDRIDGE, W. M. AND OLDENDORF, W. H.: Kinetics of regional blood-brain barrier glucose transport and cerebral blood flow determined with the carotid injection technique in conscious rats. J. Neurochem. 44:911-915, 1985.
7. BRENNEMAN, D. E., WESTBROOK, G. L., FITZGERALD, S. P., ENNINST, D. L., ELKINS, K. L., RUFF, M. R. AND PERT, C. B.: Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642, 1988.
8. BRETT, C. M., WASHINGTON, C. B., OTT, R. J., GUTIERREZ, M. M. AND GIACOMINI, K. M.: Interaction of nucleoside analogues with the sodium-nucleoside transport system in brush-border membrane vesicles from human kidney. Pharmaceut. Res. 10: 423-426, 1993.
9. CASS, C. E. AND PATERSON, A. R. P.: Mediated transport of nucleosides in human erythrocytes: Accelerative exchange diffusion of uridine and thymidine and specificity toward pyrimidine nucleosides as permeants. J. Biol. Chem. 247: 3314-3320, 1972.
10. CASS, C. E. AND PATERSON, A. R. P.: Mediated transport of nucleosides by human erythrocytes: Specificity toward purine nucleosides as permeants. Biochim. Biophys. Acta 291: 734-736, 1973.
11. CLOAD, P. A.: A review of the pharmacokinetics of zidovudine in man. J. Clin. Invest. 18: 15-21, 1989.
12. COLLINS, J. M. AND DEDRICK, R. L.: Distributed model for drug delivery to CSF and brain tissue. Am. J. Physiol. 245: R303-R310, 1983.
13. COLLINS, J. M., KLECKER, R. W., KELLEY, J. A., ROTH, J. S., MCCULLY, C. L., BALIS, F. M. AND POPLACK, D. G.: Pyrimidine dideoxynucleosides: Selectivity of penetration into cerebrospinal fluid. J. Pharmacol. Exp. Ther. 245: 466-470, 1988.
14. COOPER, D. A., GATELL, J. M., KROON, S., CLUMECK, N., MILLARD, J., GOEBEL, F.-D., BRUUN, J. N., STINGL, G., MELVILLE, R. L., GONZALEZ-LAHOZ, J., STEVENS, J. W. AND FIDDIAN, A. P.: Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N. Engl. J. Med. 329: 297-303, 1993.
15. CORNFORD, E. M. AND OLDENDORF, W. H.: Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim. Biophys. Acta 394: 211-219, 1975.
16. CSERR, H. F., COOPER, D. N., SURI, P. K. AND PATLAK, C. S.: Efflux of radiolabelled polyethylene glycols and albumin from rat brain. Am. J. Physiol. 240: F319-F328, 1981.
17. DAVSON, H., HOLLINGSWORTH, J. G., CAREY, M. B. AND FENSTERMACHER, J. D.: Ventriculo-cisternal perfusion of twelve amino acids in the rabbit. J. Neurobiol. 13: 293-318, 1982.
18. DAVSON, H., KLEEMAN, C. R. AND LEVIN, E.: Blood-brain barrier and extracellular space. J. Physiol. 159: 67P-68P, 1961.
19. DAVSON, H. AND SEGAL, M. B.: Blood-brain barrier. In: The Physiology of the CSF and Blood-Brain Barriers, pp. 49-91. CRC Press Inc., London, 1996.
20. DE MIRANDA, P., BURNETTE, T. C. AND GOOD, S. S.: Tissue distribution and metabolic disposition of zidovudine in rats. Drug Metab. Dispos. 18: 321-326, 1990.
21. DOMIN, B. A., MAHONY, W. B., KOSZALKA, G. W., PORTER, D. J. T., HAJIAN, G. AND ZIMMEKMAN, T. P.: Membrane permeation characteristics of 5′-modified thymidine analogues. Mol. Pharmacol. 41: 950-956, 1992.
22. ELLISON, S., TERASAKI, T. AND PARDRIDGE, W. M.: AZT and dideoxynucleosides do not cross the blood-brain barrier (Abstract). Clin. Res. 36: 117A, 1988.
23. FURMAN, P. A., FYFE, J. A., ST. CLAIR, M. H., WEINHOLD, K., RIDEOUT, J. L., FREEMAN, G. A., LEHRMAN, S. N., BOLOGNESI, D. P., BRODER, S., MITSUYA, H. AND BARRY, D. W.: Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 83: 8333-8337, 1986.
24. GALINSKY, R. E., HOESTEREY, B. L. AND ANDERSON, B. D.: Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection. Life Sci. 47: 781-788, 1990.
25. GALLO, J. M., SANZGIRI, Y., HOWERTH, E. W., FINCO, T. S., WILSON, J., JOHNSTON, J., TACKETT, R. AND BUDSBERG, S. C.: Serum, cerebrospinal fluid and brain concentrations of a new zidovudine formulation following chronic administration via an implantable pump in dogs. J. Pharm. Sci. 81: 11-15, 1992.
26. GATI, W. P., MISRA, H. K., KNAUS, E. E. AND WIEBE, L. I.: Structural modifications at the 2′- and 3′-positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter. Biochem. Pharmacol. 33: 3325-3331, 1984.
27. GOLDMAN, H. AND SAPIRSTEIN, L. A.: Brain blood flow in the conscious and anesthetized rat. Am. J. Physiol. 224: 122-126, 1973.
28. +-nucleoside transport in brush-border membrane vesicles from human kidney. Biochim. Biophys. Acta 1149: 202-208. 1993.
29. 3H]Nitrobenzylthioinosine binding to the guinea-pig CNS nucleoside transport system: A pharmacological characterization. J. Neurochem. 43: 1582-1592, 1984.
30. HEDAYA, M. A. AND SAWCHUK, R. J.: Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit. J. Pharm. Sci. 78: 716-722, 1989.
31. HO, D. D., ROTA, T. R., SCHOOLEY, R. T., KAPLAN, J. C., ALLAN, J. D., GROOPMAN, J. E., RESNICK, L., FELSENSTEIN, D., ANDREWS, C. A AND HIRSCH, M. S.: Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N. Engl. J. Med. 313: 1493-1497, 1985.
32. HU, M.: Comparison of uptake characteristics of thymidine and zidovudine in a human intestinal epithelial model system. J. Pharm. Sci. 82: 829-833, 1993.
33. KAHN, J. O., LAGAKOS, S. W., RICHMAN, D. D., CROSS, A., PETITNELLI, C., LIOU, S.-H., BROWN, M., VOLBERDING, P. A., CRUMPACKER, C. S., BEALL, G., SACKS, H. S., MERIGAN, T. C., BELTANGADY, M., SMALDONE, L. AND DOLIN, R.: A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N. Engl. J. Med. 327: 581-587, 1992.
34. KEEP, R. F. AND JONES, H. C.: A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Dev. Brain Res. 56: 47-53, 1990.
35. KLECKER, R. W., COLLINS, J. M., YARCHOAN, R., THOMAS, R., JENKINS, J. F., BRODER, S. AND MYERS, C. E.: Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: A novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin. Pharmacol. Ther. 41: 407-412, 1987.
36. MAEHLEN, J., DUNLOP, O., LIESTOL, K., DOBLONG, J. H., GOPLENAK AND TURVIKA, D. D.: Changing incidence of HIV induced brain lesions in Oslo 1983-1984: Effects of zidovudine treatment. AIDS 9: 1165-1169, 1995.
37. 3H]Nitrobenzylthioinosine binding as a probe for the study of adenosine uptake sites in brain. J. Neurochem. 39: 184-191, 1982.
38. MASEREEUW, R., JAEHDE, U., LANGEMEIJER, M. W. E., DE BOER, A. G. AND BREIMER, D. D.: In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors. Pharm. Res. 11: 324-330, 1994.
39. MERRILL, J. E. AND CHEN, I. S. Y.: HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease. FASEB J. 5: 2391-2397, 1991.
40. MITSUYA, H., WEINHOLD, K. J., FURMAN, P. A., ST. CLAIR, M. H., LEHRMAN, S. N., GALLO, R. C., BOLOGNESI, D., BARRY, D. AND BRODER, S.: 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. U.S.A. 82: 7096-7100, 1985.
41. PANG, S., KOYANGI, Y., MILES, S., VINTERS, H. AND CHEN, I. S. Y.: The structure of HIV DNA in brain and blood of AIDS patients. Nature 343: 85-90, 1990.
42. PATERSON, A. R. P., KOLASSA, N. AND CASS, C. E.: Transport of nucleoside drugs in animal cells. Pharmac. Ther. 12: 515-536, 1981.
43. PLAGEMANN, P. G. W., WOHLHUETER, R. M. AND WOFFENDIN, C.: Nucleoside and nucleobase transport in animal cells. Biochim. Biophys. Acta 947: 405-443, 1988.
44. POWER, C., KONG, P.-A., CRAWFORD, T. O., WESSELINGH, S., GLASS, J. D., MCARTHUR, J. C. AND TRAPP, B.D.: Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 34: 339-350, 1993.
45. SMITH, T. W., DE GIROLANI, U., HENIN, D., BOLGEKT, F. AND HAUM, J. J.: Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 49: 357-370, 1990.
46. SNIDER, W. D., SIMPSON, D. M., NIELSON, S., GOLD, J. N. M., METROKA, C. E. AND POSNER, J. B.: Neurological complications of acquired immune deficiency syndrome; Analysis of 50 patients. Ann. Neurol. 14: 403-418, 1983.
47. SPECTOR, R.: Nucleoside transport in choroid plexus: Mechanism and specificity. Arch. Biochem. Biophys. 216: 693-703, 1982a.
48. SPECTOR, R.: Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system. J. Pharmacol. Exp. Ther. 222: 1-6, 1982b.
49. SPECTOR, R. AND HUNTOON, S.: Specificity and sodium dependence of the active nucleoside transport system in churoid plexus. J. Neurochem. 42: 1048-1052, 1984.
50. SZENTESVANYI, I., PATLAK, C. S., ELLIS, R. A. AND CSERR, H. F.: Drainage of interstitial fluid from different regions of the rat brain. Am. J. Physiol. 246: F835-F844, 1984.
51. TAUBE, R. A. AND BERLIN, R. D.: Membrane transport of nucleosides in rabbit polymorphonuclear leukocytes. Biochim. Biophys. Acta 255: 6-18, 1972.
52. TERASAKI, T. AND PARDRIDGE, W. M.: Restricted transport of azidodeoxythymidine and dideoxynucleosides through the blood-brain barrier. J. Infect. Dis. 158: 630-632, 1988.
53. 3H]thymidine in the anesthetized rabbit. Exp. Phys. 82: 139-148, 1997.
54. THOMAS, S. A. AND SEGAL, M. B.: Identification of a saturable uptake system for deoxyribonucleosides at the blood-brain and blood-cerebrospinal fluid barriers. Brain Res. 741: 230-239, 1996.
55. WILEY, C. A., SCHRIER, R. D., NELSON, J. A., LAMPERT, P. W. AND OLDSTONE, M. B. A.: Cellular localisation of human immunodeficiency virus infection within the brain of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U.S.A. 83: 7089-7093, 1986.
56. 2.5]enkephalin, across the blood-brain and blood-cerebrospinal fluid barriers. J. Neurochem. 66: 1289-1299, 1996.
57. WU, X., GUTIERREZ, M. M. AND GIACOMINI, K. M.: Further characterisation of the sodium-dependent nucleoside transporter (N3) in choroid plexus from rabbit. Biochim. Biophys. Acta 1191: 190-196, 1994.
58. WU, X., YUAN, G., BRETT, C. M., HUI, A. C. AND GIACOMINI, K. M.: Sodium-dependent nucleoside transport in choroid plexus from rabbit. J. Biol. Chem. 267: 8813-8818, 1992.
59. YARCHOAN, R., BERG, G., BROUWERS, P., SPITZER, A. R., GRAFMAN, J., SAFAL, B., PERNO, C. F., LARSON, S. M., FISCHL, M. A., WICHMAN, A., THOMAS, R. V., BRUNETTI, A., SCHMIDT, P. J. AND MYERS, C. E.: Response of human-immunodeficiency-virus-associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet 1: 132-135, 1987.
60. YARCHOAN, R., KLECKER, R. W., WEINHOLD, K. J., MARKHAM, P. D., LYERLY, H. K., DURACK, D. T., GELMANN, E., NUSINOFF-LEHRMAN, S., BLUM, R. M., BARRY, D. W., SCHEARER, G. M., FISCHL, M. A., MITSUYA, H., GALLO, R. C., COLLINS, J. M., BOLOGNESI, D. P., MYERS, C. E. AND BRODER, S.: Administration of 3′-azido-3′-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet 1: 575-580, 1986.
61. YARCHOAN, R., MITSUYA, H., MYERS, C. E. AND BRODER, S.: Clinical pharmacology of 3′-azido-2′, 3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N. Engl. J. Med. 321: 726-738, 1989.
62. ZIMMERMAN, T. P., MAHONY, W. B AND PRUS, K. L.: 3′-Azido-3′-deoxythymidine: An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by non-facilitated diffusion. J. Biol. Chem. 262: 5748-5754, 1987.